Molecular Subtypes and Local-Regional Control of Breast Cancer
- PMID: 29132568
- PMCID: PMC5715810
- DOI: 10.1016/j.soc.2017.08.005
Molecular Subtypes and Local-Regional Control of Breast Cancer
Abstract
In the era of personalized medicine, there has been significant progress regarding the molecular analysis of breast cancer subtypes. Research efforts have focused on how classification of subtypes could provide information on prognosis and influence treatment planning. Although much is known about the impact of different molecular subtypes on disease-specific survival, more recent studies have investigated the role of the different molecular subtypes on local-regional recurrence. This is an area of active study, and in recent years there has been significant progress. This article describes outcomes among disease subtypes to aid in optimal surgical decision-making to improve local-regional control.
Keywords: Breast cancer; Gene signatures; Immunohistochemical surrogates; Local-regional recurrence; Molecular subtypes.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.Int J Med Sci. 2021 Jan 1;18(3):626-638. doi: 10.7150/ijms.49544. eCollection 2021. Int J Med Sci. 2021. PMID: 33437197 Free PMC article. Review.
-
Precision treatment exploration of breast cancer based on heterogeneity analysis of lncRNAs at the single-cell level.BMC Cancer. 2021 Aug 13;21(1):918. doi: 10.1186/s12885-021-08617-7. BMC Cancer. 2021. PMID: 34388989 Free PMC article.
-
Molecular profiling: an essential technology enabling personalized medicine in breast cancer.Curr Drug Targets. 2012 Apr;13(4):541-54. doi: 10.2174/138945012799499767. Curr Drug Targets. 2012. PMID: 22250651 Review.
-
The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.Breast Cancer Res Treat. 2017 Aug;165(1):65-76. doi: 10.1007/s10549-017-4326-1. Epub 2017 Jun 3. Breast Cancer Res Treat. 2017. PMID: 28577081 Free PMC article.
-
The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment.Int J Mol Sci. 2021 Aug 1;22(15):8290. doi: 10.3390/ijms22158290. Int J Mol Sci. 2021. PMID: 34361056 Free PMC article. Review.
Cited by
-
De-Escalating Treatment Strategies for Patients with Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Early-Stage Breast Cancer.Cancers (Basel). 2024 Oct 14;16(20):3478. doi: 10.3390/cancers16203478. Cancers (Basel). 2024. PMID: 39456572 Free PMC article. Review.
-
Epidemiology of Breast Cancer in Mexican Women with Obesity as a Risk Factor.Int J Mol Sci. 2022 Sep 15;23(18):10742. doi: 10.3390/ijms231810742. Int J Mol Sci. 2022. PMID: 36142655 Free PMC article.
-
Computer-Aided Ligand Discovery for Estrogen Receptor Alpha.Int J Mol Sci. 2020 Jun 12;21(12):4193. doi: 10.3390/ijms21124193. Int J Mol Sci. 2020. PMID: 32545494 Free PMC article. Review.
-
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell Lines.Cancers (Basel). 2020 Jul 6;12(7):1811. doi: 10.3390/cancers12071811. Cancers (Basel). 2020. PMID: 32640677 Free PMC article.
-
Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines.Int J Mol Sci. 2024 Jan 25;25(3):1471. doi: 10.3390/ijms25031471. Int J Mol Sci. 2024. PMID: 38338747 Free PMC article.
References
-
- Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–752. - PubMed
-
- Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367–5374. - PubMed
-
- Millar EKA, Graham PH, O’Toole SA, et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol. 2009;27(28):4701–4708. - PubMed
-
- Voduc KD, Cheang MCU, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol. 2010;28(10):1684–1691. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical